Drug maker Pfizer Inc. (NYSE: PFE) today announced that it has reached settlements with the US Justice Department and the Securities and Exchange Commission related to improper payments (aka, bribes) paid by six of…
Johnson & Johnson Inc. (NYSE: JNJ) and Pfizer Inc. (NYSE: PFE) both announced they are stopping development of a drug to treat patients with mild to moderate Alzheimer’s after the drug failed a second clinical…
Hospital operator HCA Holdings Inc. (NYSE: HCA) reported a better-than-expected second-quarter profit due to higher patient admissions. Net income for the quarter rose to $391 million, or $0.85 cents per share, on $8.11 billion…
Gilead Sciences Inc. (NASDAQ: GILD) is seeing shares surge today on news that Bristol-Myers Squibb Co. (NYSE: BMY) has run into some unforseen safety issues with a hep-C candidate called INX-189. Gilead’s rival treatment…
Walgreen Co. (NYSE: WAG) has announced that it has completed its investment in Alliance Boots, an international pharmacy-led health and beauty group. The deal has received all regulatory approvals despite the size of the…
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) remains stuck after its earnings report. The generic and branded pharmaceutical drug maker turned in higher earnings that only met expectations. The company claims to be on track…
With the company’s annual shareholders’ meeting set for August 15, Forest Laboratories Inc. (NYSE: FRX) continues its proxy fight with activist investor Carl Icahn, who has proposed a slate of four candidates for the…
Pfizer Inc. (NYSE: PFE) reported second-quarter adjusted earnings per share (EPS) of $0.62 and $15.06 billion in revenue this morning. Adjusted EPS was up from $0.59 in the same period a year ago, while…
The U.S. Food & Drug Administration has sent Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) and Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) a Complete Response Letter (CRL) regarding the drug Relistor’s supplemental new drug application. Relistor is an injection…
Usually, shares of drug makers soar following the announcement that the Foood and Drug Administration approved a drug. Amarin Corp. (NASDAQ: AMRN) announced approval by the FDA for Vascepta to patients very high triglycerides. Yet, shares…
Amgen Inc. (NASDAQ: AMGN) today announced financial results for the second quarter of 2012. The biotech giant’s results showed a 13% revenue gain to $4.5 billion and adjusted earnings rose 34% to $1.83 per…
GileadGilead Sciences, Inc. (NASDAQ: GILD) has a product chest that includes Atripla, Truvada, Viread, Complera/Eviplera, and Emtriva for the treatment of HIV infection in adults. While Gilead has been diversifying its products and its…
Activist investing can sometimes be a bit like a tennis match to watch. And sometimes it can yield great profits for investors. Carl Icahn is picking up his attack on Forest Laboratories, Inc. (NYSE:…
A new treatment for Alzheimer’s disease from Pfizer Inc. (NYSE: PFE) and partner Elan Corp. plc (NYSE: ELN) has failed a late-stage trial in patients with mild-to-moderate cases of the disease and who are…
Shares of Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) were halted for about half an hour this morning pending an announcement from the company. Shares were up 5.2% when trading in the stock was stopped. At…